BIOMAT Database Logo BIOMAT Database Logo

Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer. 2020

Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, 100142, Beijing, People's Republic of China.

Heterogeneity with respect to recurrence and survival in high-risk stage II colon cancer patients still exists, and further classification is urgently required. This study aimed to ascertain the prognostic value of DNA ploidy, stroma-tumour fraction and nucleotyping in the prognosis of high-risk stage II colon cancer. A total of 188 high-risk stage II colon cancer patients received radical surgery in Peking University Cancer Hospital, from 2009 to 2015. Status of mismatch repair proteins in tumours was analysed using immunohistochemistry. DNA ploidy, stroma-tumour fraction and nucleotyping were estimated by automated digital imaging systems. Nucleotyping and DNA ploidy were significant prognostic factors, while stroma-tumour fraction were not significantly prognostic in the univariate analysis. In the multivariable model, the dominant contributory factor of disease-free survival was chromatin heterogeneous vs. chromatin homogeneous [HR 3.309 (95% CI: 1.668-6.564), P = 0.001]. Our study indicates that nucleotyping is an independent prognostic factor in high-risk stage II colon cancer. Therefore, it may help subdivide patients into different subgroups and give them different strategies for follow-up and treatment in the future.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Prognostic value of DNA ploidy in breast cancer stage I-II.
January 1997, Neoplasma,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.
August 2020, International journal of cancer,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer.
January 2023, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
[Prognostic value of DNA ploidy in prostatic cancer].
April 2001, Actas urologicas espanolas,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer.
January 2021, Frontiers in oncology,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Prognostic value of stem cell quantification in stage II colon cancer.
January 2014, PloS one,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Prognostic value of humbug gene overexpression in stage II colon cancer.
January 2007, Human pathology,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
August 2018, International journal of colorectal disease,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
January 1998, Cancer,
Lujing Yang, and Pengju Chen, and Li Zhang, and Lin Wang, and Tingting Sun, and Lixin Zhou, and Zhongwu Li, and Aiwen Wu
Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer.
July 2018, British journal of cancer,
Copied contents to your clipboard!